Voce Capital Management LLC Company Profile

23:23 EDT 3rd July 2015 | BioPortfolio

Voce Capital Management LLC is an employee-owned investment manager and the adviser to Voce Catalyst Partners LP (the √ʬĬúFund√ʬĬĚ). The Fund is a long/short equity investment partnership which invests in small capitalization companies.


News Articles [738 Associated News Articles listed on BioPortfolio]

ITG Enters Into Cooperation Agreement With Philadelphia Financial and Voce Capital and Adds Independent Director

NEW YORK, April 9, 2015 (GLOBE NEWSWIRE) -- ITG (NYSE:ITG) (or the "Company"), an independent execution broker and research provider, today announced that it has reached an agreement with shareholder...

Clemetia brings in $60mm through mezzanine financing

Clementia Pharmaceuticals Inc. raised $60mm in an oversubscribed mezzanine financing round led by New Enterprise Associates, which was joined by returning shareholders OrbiMed Advisors and BDC Capital...

Allergen Research raises $80mm through Series B round

Allergen Research Corp. raised $80mm in its Series B round from new investors Foresite Capital (lead), Fidelity Management & Research, Aisling Capital, Adage Capital, RA Capital Management, and Palo A...

Evotec-Aktie: Leerverk√§ufer BlueCrest Capital Management zieht sich zur√ľck - Shortposition abgebaut - Aktiennews

Hamburg - Leerverkäufer BlueCrest Capital Management reduziert Netto-Leerverkaufsposition in Aktien der Evotec AG: Die Leerverkäufer von BlueCrest Capital Management Limited haben ihr Short-Engagem....

MorphoSys-Aktie: Short-Attacke von Leerverkäufer BlueCrest Capital Management geht weiter - Aktiennews

Martinsried - Leerverkäufer BlueCrest Capital Management erhöht Netto-Leerverkaufsposition in MorphoSys-Aktien: Die Leerverkäufer von BlueCrest Capital Management Limited haben ihre Shortposition i...

MorphoSys-Aktie: Leerverk√§ufer BlueCrest Capital Management zieht sich zur√ľck - Aktiennews

Martinsried - Leerverkäufer BlueCrest Capital Management baut Netto-Leerverkaufsposition in MorphoSys-Aktien ab: Die Leerverkäufer von BlueCrest Capital Management Limited haben ihre Shortposition ....

MorphoSys-Aktie: Short-Attacke von Leerverkäufer BlueCrest Capital Management - Aktiennews

Martinsried - Leerverkäufer BlueCrest Capital Management eröffnet Netto-Leerverkaufsposition in MorphoSys-Aktien Die Leerverkäufer von BlueCrest Capital Management Limited haben eine Shortposition ...

Adaptive Biotechnologies closes $195mm Series F round

Matrix Capital Management led a $195mm Series F round for immunosequencing diagnostics firm Adaptive Biotechnologies Inc. Other new investors Senator Investment Group, Tiger Management, Rock Springs C...

PubMed Articles [2151 Associated PubMed Articles listed on BioPortfolio]

Study protocol: SWING - social capital and well-being in neighborhoods in Ghent.

Investing in social capital has been put forth as a potential lever for policy action to tackle health inequity. Notwithstanding, empirical evidence that supports social capital's role in the existenc...

THOUGHTS ON AN INTEGRATIVE APPROACH TO TEACH WELLNESS WITHIN THE CONTEXT OF A TRADITIONAL SCIENCE/BIOENGINEERING CURRICULUM.

Engineers and scientists are valuable resources to society and might be referred to as human capital. Faculties are charged with protecting society’s investment in human capital by developing compete...

In search of links between social capital, mental health and sociotherapy: A longitudinal study in Rwanda.

To date, reviews show inconclusive results on the association between social capital and mental health. Evidence that social capital can intentionally be promoted is also scarce. Promotion of social c...

Social Capital and Self-Rated Health Among Middle-Aged and Older Adults in China: A Multilevel Analysis.

This study examined the association between social capital, at both the individual and the community level, and self-rated health among older adults in China. Using data from the 2008 Pilot Survey of ...

Co-Circulation of Dengue Virus Type 3 Genotypes in Vientiane Capital, Lao PDR.

During the 2012 epidemic of dengue in Vientiane capital, Lao PDR, a major serotype switch from dengue 1 to 3 was observed. A molecular epidemiology study demonstrated that dengue 3 remained the predom...

Clinical Trials [1429 Associated Clinical Trials listed on BioPortfolio]

Treatment of Sub-Capital Fractures of Hip Joint by Using TriboFit‚ĄĘ Acetabular Buffer

The purpose of this study is to determine the performance and efficacy during 6 and 12 month post operation. 1. determine changes in patient pain level 2. determine changes in ...

Hepatitis C Self-Management

The objective of this study is to compare the efficacy of a 6-session hepatitis C self-management workshop to a hepatitis C self-management self-study program. Both interventions are desig...

Contingency Management Treatment Duration

310 alcohol abusing or dependent patients beginning intensive outpatient day treatment at community-based clinics will be randomly assigned to one of four conditions: (a) standard treatmen...

Self-Management Addressing Heart Disease Risk Trial

The purpose of this research study is to learn whether or not people with bipolar disorder can reduce their risk of heart disease and related conditions by having a Care Manager provide se...

Postoperative Canadian Oral Anticoagulation Self-Management (Post-COAGS) Trial

This study will measure the efficacy and safety of an early postoperative anticoagulation self-management program, using the CoaguChek S device, in patients undergoing mechanical valve rep...

Companies [2039 Associated Companies listed on BioPortfolio]

Voce Capital Management LLC

Voce Capital Management LLC is an employee-owned investment manager and the adviser to Voce Catalyst Partners LP (the √ʬĬúFund√ʬĬĚ). The Fund is a long/short equity investment...

Ares Capital Corporation

Ares Capital is a closed-end, non-diversified management investment company that has elected to be regulated as a business development company under the Investment Company Act of ...

Irving Place Capital

Irving Place Capital invests private equity capital in buyouts, recapitalizations, and growth capital opportunities alongside superior management teams. Irving Place Capital focus...

Praesidian Capital

Praesidian Capital partners with small and mid-sized businesses, providing private debt capital. With a focus on its core competency in mezzanine financing, Praesidian Capital invests in established, ...

Sorenson Capital

Sorenson Capital (www.sorensoncapital.com) is a private equity firm that makes small to middle-market buyout and growth equity investments. Sorenson Capital has over one billion i...

More Information about "Voce Capital Management LLC" on BioPortfolio

We have published hundreds of Voce Capital Management LLC news stories on BioPortfolio along with dozens of Voce Capital Management LLC Clinical Trials and PubMed Articles about Voce Capital Management LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Voce Capital Management LLC Companies in our database. You can also find out about relevant Voce Capital Management LLC Drugs and Medications on this site too.


Advertisement
 

Relevant Topic

Mergers & Acquisitions
Latest News Clinical Trials Research Drugs Reports Corporate
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record